Back to 
Bank of New York Mellon CorpWEWEK
Bank of New York Mellon CorpWEWEKShowing 0 of 19 quarters
Position history for Bank of New York Mellon Corp's holdings in ZIOPHARM ONCOLOGY INC
As of its Q4 2023 13F, Bank of New York Mellon held 102,692 shares of WEK (Ziopharm Oncology), worth $7,260. Bank of New York Mellon's 13F filings listed WEK from Q3 2019 to Q4 2023, 18 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of WEK: MSD Partners, L.P., MILLER VALUE PARTNERS, LLC